CMS Reimbursement-Ready†
Diabetes &
Chronic Care
Programs®
with AI-Enabled Solutions
Embedded Files
$100 Comprehensive Neuropathy Testing (Small & Large Fibers)
Exclusively for Healthcare Providers
Exclusively for Healthcare Providers
We help clinics test and treat chronic conditions using reimbursement-ready technologies before referrals are needed.
You are the Future of diabetes care
You are the Future of diabetes care
Before...
Alzheimer’s dims minds,
Amputations end walks,
Heart attacks shatter bonds,
Bring hope and healing.
find what others miss
At Diabetes Testing Centers™ (DTC), we were founded by former family practice owners who saw the consequences of delayed detection, missed reimbursements, and preventable complications in everyday care. With a provider network of more than 20,000 clinics nationwide, our mission is to close these gaps for patients with diabetes and other chronic conditions from head-to-toe through innovative, non-invasive, point-of-care technology. We provide turnkey ancillary programs that are CMS reimbursement-ready, can improve care, and reduce costs—all while aligning with an organization’s unique care philosophy. This model also creates opportunities to collaborate with enterprise-level, tech-forward health systems that can redefine patient access to chronic care services.
Our Diabetes & Chronic Care Programs® are designed for comprehensive assessments, longitudinal, multi-visit care, and structured pathways (18+ visits) to monitor progress and adjust treatment plans. These programs create ongoing preventive pathways with recurring reimbursable visits that allow providers to track progress, adapt care, and strengthen outcomes over time. Clinical evidence places neuropathy firmly at the front of the diabetes complications, making it the most common and earliest complication of diabetes, affecting up to 50% of patients. Addressing neuropathy early not only secures vital clinical data and reimbursable revenue but also interrupts the cascade of complications that often follow.
Prescribed Treatment Encounters
Objective Assessments. Evidence-based, non-invasive tests (neuropathy, cognition, psych, cardiovascular, etc.) that give providers measurable data to identify risks early and personalize treatment plans.
Long-Term Therapeutic Care. Multi-visit programs (18–36 encounters) where patients receive ongoing therapy, monitoring, and adjustments—building preventive pathways and recurring reimbursement.
This dual approach lets you proactively identify risks tied to diabetic neuropathy and other chronic conditions while strengthening in-house care. By using our solutions, we can help more families keep their time together longer.
Preventable Diseases Shouldn't Be Fatal
Pick A pathway
Add reimbursable treatments to your existing assessments, instead of referring them out.
Early Detection Matters
Early Detection Matters
Early Detection Gives Families More Time and Memories to Share.
Early Testing Matters
Early Testing Matters
Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable.
Each test is based on medical necessity for early detection, requires an average of three minutes or less to administer, and targets the complications most likely to affect patients with diabetes.
Quick Assessment Examples
Diabetic Peripheral Neuropathy (DPN): Studies estimate that up to 50% of patients with diabetes will develop some form of neuropathy during their lifetime. Small-fiber damage is often the first, years before large-fiber involvement and can precede other microvascular complications like retinopathy and nephropathy (American Diabetes Association, Diabetes Care).
Cognitive Dysfunction: Neurological impairment is recognized as a diabetes complication, with evidence suggesting cognitive decline occur simultaneously with neuropathy due to shared microvascular and inflammatory pathways (Kodl & Seaquist, Nature Reviews Endocrinology).
Psychological Disorders: Depression and anxiety are highly prevalent in patients with painful diabetic neuropathy. Published studies in Diabetes Care, Pain, and the Journal of Neurology, Neurosurgery & Psychiatry report rates as high as 60%. These comorbidities complicate self-management, worsen outcomes, and increase overall healthcare utilization.
Our exclusive 25 turnkey Diabetes & Chronic Care Programs® are designed for primary care and multispecialty settings and chronic patients. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver CMS reimbursement-ready programs—many of which do not require new staff, new construction, or disruption to your workflow.
By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.
25 Programs. 1 Exam Room.
National Guidelines
National guidelines recommend that primary care physicians, endocrinologists, podiatrists, and neuropathy specialists screen all diabetic patients for neuropathy at least once a year. Neuropathy is one of the earliest and most common complications of diabetes, and its detection has important clinical implications.
Small fiber neuropathy is often the first sign of metabolic dysfunction or poorly controlled diabetes, serving as an early warning that systemic complications may be developing.
Large fiber neuropathy, on the other hand, is closely tied to loss of protective sensation—leading to falls, infections, wounds, and ultimately amputations and inspected at every visit once identified.
When neuropathy is detected, it not only signals nerve damage but also indicates an elevated risk of other serious diabetes-related complications such as cardiovascular disease, renal decline, and vision loss, all of which share the same underlying metabolic origin. When you can Screen, Test and Treat in-house and remotely, you not only keep patients under your care, you break the chain reaction at its source. That’s what makes our Chronic Care Programs® more than just assessments, they are the bridge between routine care and long-term health.
Neuropathy is a serious condition that, if not accurately diagnosed and treated promptly, can lead to devastating outcomes, such as amputations of the toes, feet, or legs. The failure to adopt advanced diagnostic tools and procedures has resulted in medical institutions and physicians being held liable for malpractice. A landmark case, Washington v. Washington Hospital (1990)., set legal precedent in the U.S. regarding this issue.
60% of People are Living with One Chronic Disease
Early Dysfunction
Early Dysfunction
Screen. Test. Treat.
Screen. Test. Treat.
Most diabetic and chronic patients never see the specialists who could detect early complications—referrals are delayed, visits missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments and therapies for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are.
Our Diabetes & Chronic Care Programs® give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams.
Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike.
Our turnkey programs make it possible to intervene earlier with rapid, non-invasive, point-of-care tools such as neuropathy testing, PAD screening, cognitive assessments, and cardiovascular risk evaluations. Each fits seamlessly into your workflow, enabling your team to detect risks, initiate treatment plans, and manage progression both in-clinic and remotely. The result is better outcomes for patients, stronger trust in your care, and new reimbursable revenue streams that support practice growth.
Neurology:
Peripheral neuropathy (feet, legs, hands)
Cognitive decline and vascular dementia
Cardiology / Vascular:
Atherosclerosis, hypertension, coronary artery disease
Peripheral artery disease (PAD), stroke risk
Endocrinology / Metabolism:
Elevated A1C, insulin resistance, dyslipidemia
Fatty liver disease (NAFLD)
Nephrology:
Diabetic nephropathy leading to chronic kidney disease or renal failure
Ophthalmology:
Diabetic retinopathy, macular edema, vision loss
Podiatry / Wound Care:
Ulcers, infections, amputations due to neuropathy and poor circulation
Why Offer In-House Specialty Testing
Most diabetic patients never see the specialists who could detect early complications—referrals are delayed, visits missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are.
Keep Your Workflow, Change Your Tools!
More Than Glucose
More Than Glucose
Primary Care Providers (PCP) check patients blood glucose but why stop there? With in-clinic neuropathy, cognitive, or vascular testing, you can diagnose earlier, act sooner, and keep care under your roof instead of waiting on outside referrals. This means you’re not just monitoring—you’re diagnosing, acting sooner, and keeping patients under your care with clinically valuable results that directly improve outcomes.
Getting Started Is Simple:
1. Identify Your Top 3 Referrals
1. Identify Your Top 3 Referrals
Think about the top three patient referrals your clinic makes, like labs, neurology, podiatry, endocrinology, cardiology, physical therapy, or others. This helps you determine which patients have unmet needs that your clinic may fulfill.
Review our Chronic Care Programs® and pick one that aligns with the referrals you make. For example, if you send a lot of patients to neurology, choose our neuropathy testing program. If you refer to cardiology, consider our cardiovascular risk evaluation, etc.
3. Schedule a Meeting Below to Get Started
3. Schedule a Meeting Below to Get Started
Select a program with a zero-down option to begin testing these patients immediately in your clinic, without any upfront investment and get a financial pro forma from us based on your location and payor reimbursements. This allows you to start providing and billing for these services, regularly in 30 days or less.
Your Next Referral Could Be A Missed Diagnosis
Schedule Below to Learn More
Schedule Below to Learn More
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.
Test Before You Refer
Test Before You Refer
Page updated
Report abuse